QSII has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
QSII has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companyยs financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | No Debt |
QSII's Cash to Debt is ranked higher than
60% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 10000.00 vs. QSII: No Debt ) |
QSII'
s 10-Year Cash to Debt Range
Min: No Debt Max: No Debt Current: No Debt |
| Equity to Asset | 0.434 |
QSII's Equity to Asset is ranked lower than
56% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 0.49 vs. QSII: 0.434 ) |
QSII'
s 10-Year Equity to Asset Range
Min: 0.36 Max: 0.73 Current: 0.43 |
| Interest Coverage | No Debt |
QSII's Interest Coverage is ranked higher than
60% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 10000.00 vs. QSII: No Debt ) |
QSII'
s 10-Year Interest Coverage Range
Min: No Debt Max: No Debt Current: No Debt |
| F-Score: 4 |
|
| Z-Score: 8.43 |
|
| M-Score: -2.49 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ยย3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 27.00 |
QSII's Operating margin (%) is ranked higher than
89% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 5.40 vs. QSII: 27.00 ) |
QSII'
s 10-Year Operating margin (%) Range
Min: 2.4 Max: 35.6 Current: 27 |
| Net-margin (%) | 17.6 |
QSII's Net-margin (%) is ranked higher than
83% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 3.50 vs. QSII: 17.6 ) |
QSII'
s 10-Year Net-margin (%) Range
Min: 1.8 Max: 21.5 Current: 17.6 |
| ROE (%) | 25.6 |
QSII's ROE (%) is ranked higher than
88% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 6.80 vs. QSII: 25.6 ) |
QSII'
s 10-Year ROE (%) Range
Min: 2 Max: 36.4 Current: 25.6 |
| ROA (%) | 17.2 |
QSII's ROA (%) is ranked higher than
90% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 4.00 vs. QSII: 17.2 ) |
QSII'
s 10-Year ROA (%) Range
Min: 1.5 Max: 22.1 Current: 17.2 |
| ROC (Joel Greenblatt) (%) | 188.40 |
QSII's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 21.20 vs. QSII: 188.40 ) |
QSII'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 14 Max: 916.3 Current: 188.4 |
| Revenue Growth (%) | 13.9 |
QSII's Revenue Growth (%) is ranked higher than
93% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 4.20 vs. QSII: 13.9 ) |
QSII'
s 10-Year Revenue Growth (%) Range
Min: 9 Max: 20.1 Current: 13.9 |
| EBITDA Growth (%) | 12.1 |
QSII's EBITDA Growth (%) is ranked higher than
89% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 6.90 vs. QSII: 12.1 ) |
QSII'
s 10-Year EBITDA Growth (%) Range
Min: 10.3 Max: 35.1 Current: 12.1 |
| EPS Growth (%) | 12.1 |
QSII's EPS Growth (%) is ranked higher than
87% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 4.85 vs. QSII: 12.1 ) |
QSII'
s 10-Year EPS Growth (%) Range
Min: 8.6 Max: 75.8 Current: 12.1 |
| Jim Simons 941,976 sh (New) Paul Tudor Jones 22,500 sh (New) Joel Greenblatt 63,548 sh (+1286%) Jeremy Grantham 48,700 sh (+4.73%) | Columbia Wanger 2,612,000 sh (unchged) | Steven Cohen Sold Out Manning & Napier Advisors, Inc Sold Out |
| John Hussman 1,500 sh (New) Steven Cohen 51,200 sh (New) Joel Greenblatt 315,677 sh (+396.75%) Paul Tudor Jones 29,200 sh (+29.78%) | Jeremy Grantham Sold Out Columbia Wanger 2,588,000 sh (-0.92%) Jim Simons 721,176 sh (-23.44%) |
| Richard Snow 518,456 sh (New) John Hussman 3,000 sh (+100%) Joel Greenblatt 330,359 sh (+4.65%) | Steven Cohen Sold Out Columbia Wanger 1,520,000 sh (-41.27%) Paul Tudor Jones 14,000 sh (-52.05%) Jim Simons 36,376 sh (-94.96%) |
| Steven Cohen 558,604 sh (New) Richard Snow 1,026,686 sh (+98.03%) | John Hussman 3,000 sh (unchged) | Jim Simons Sold Out Paul Tudor Jones Sold Out Columbia Wanger Sold Out Joel Greenblatt 175,553 sh (-46.86%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Richard Snow | 2013-03-31 | Add 98.03% | 0.45% | $17.34 - $19.45 | $ 19.18 | 4% | 1026686 | |
| Joel Greenblatt | 2013-03-31 | Reduce -46.86% | 0.15% | $17.34 - $19.45 | $ 19.18 | 4% | 175553 | |
| Richard Snow | 2012-12-31 | New Buy | 0.51% | $16.71 - $18.87 | $ 19.18 | 7% | 518456 | |
| John Hussman | 2012-12-31 | Add 100% | $16.71 - $18.87 | $ 19.18 | 7% | 3000 | ||
| Joel Greenblatt | 2012-09-30 | Add 396.75% | 0.31% | $15.95 - $28.01 | $ 19.18 | -6% | 315677 | |
| John Hussman | 2012-09-30 | New Buy | $15.95 - $28.01 | $ 19.18 | -6% | 1500 | ||
| Joel Greenblatt | 2012-06-30 | Add 1286% | 0.12% | $24.6 - $43.91 | $ 19.18 | -42% | 63548 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 18.50 |
QSII's P/E(ttm) is ranked higher than
82% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 25.05 vs. QSII: 18.50 ) |
QSII'
s 10-Year P/E(ttm) Range
Min: 13.29 Max: 58.73 Current: 18.5 |
| P/B | 3.87 |
QSII's P/B is ranked lower than
71% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 1.90 vs. QSII: 3.87 ) |
QSII'
s 10-Year P/B Range
Min: 1.19 Max: 15.65 Current: 3.87 |
| P/S | 2.48 |
QSII's P/S is ranked lower than
64% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 1.40 vs. QSII: 2.48 ) |
QSII'
s 10-Year P/S Range
Min: 1.1 Max: 11.23 Current: 2.48 |
| PFCF | 38.36 |
QSII's PFCF is ranked lower than
55% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 18.41 vs. QSII: 38.36 ) |
QSII'
s 10-Year PFCF Range
Min: 9.02 Max: 64.91 Current: 38.36 |
| EV-to-EBIT | 10.93 |
QSII's EV-to-EBIT is ranked higher than
82% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 18.35 vs. QSII: 10.93 ) |
QSII'
s 10-Year EV-to-EBIT Range
Min: 6.5 Max: 30.3 Current: 10.93 |
| PEG | 1.1 |
QSII's PEG is ranked higher than
97% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 1.37 vs. QSII: 1.1 ) |
QSII'
s 10-Year PEG Range
Min: 0.52 Max: 2.55 Current: 1.1 |
| Shiller P/E | 19.52 |
QSII's Shiller P/E is ranked higher than
89% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 22.91 vs. QSII: 19.52 ) |
QSII'
s 10-Year Shiller P/E Range
Min: 16.95 Max: 121.71 Current: 19.52 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 3.65 |
QSII's Dividend Yield is ranked higher than
93% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 2.00 vs. QSII: 3.65 ) |
QSII'
s 10-Year Dividend Yield Range
Min: 0.59 Max: 4.3 Current: 3.65 |
| Dividend Payout | 0.2 |
QSII's Dividend Payout is ranked higher than
87% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 0.85 vs. QSII: 0.2 ) |
QSII'
s 10-Year Dividend Payout Range
Min: 0.55 Max: 0.71 Current: 0.2 |
| Dividend growth (3y) | 5 |
QSII's Dividend growth (3y) is ranked higher than
97% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: -3.10 vs. QSII: 5 ) |
QSII'
s 10-Year Dividend growth (3y) Range
Min: 0 Max: 5.7 Current: 5 |
| Yield on cost (5-Year) | 5.41 |
QSII's Yield on cost (5-Year) is ranked higher than
96% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 2.00 vs. QSII: 5.41 ) |
QSII'
s 10-Year Yield on cost (5-Year) Range
Min: 0.86 Max: 6.29 Current: 5.41 |
| Share Buyback Rate | -1 |
QSII's Share Buyback Rate is ranked higher than
76% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: -1.20 vs. QSII: -1 ) |
QSII'
s 10-Year Share Buyback Rate Range
Min: 1.6 Max: -1.7 Current: -1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 10.1 |
QSII's Price/Net Current Asset Value is ranked higher than
77% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 13.80 vs. QSII: 10.1 ) |
QSII'
s 10-Year Price/Net Current Asset Value Range
Min: 6.3 Max: 25.9 Current: 10.1 |
| Price/Tangible Book | 6 |
QSII's Price/Tangible Book is ranked higher than
86% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 3.85 vs. QSII: 6 ) |
QSII'
s 10-Year Price/Tangible Book Range
Min: 2.1 Max: 16.6 Current: 6 |
| Price/DCF (Projected) | 1.4 | ||
| Price/Median PS Value | 0.5 |
QSII's Price/Median PS Value is ranked higher than
60% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 0.80 vs. QSII: 0.5 ) |
QSII'
s 10-Year Price/Median PS Value Range
Min: 0.3 Max: 1.6 Current: 0.5 |
| Price/Peter Lynch Fair Value | 0.8 |
QSII's Price/Peter Lynch Fair Value is ranked higher than
90% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 1.90 vs. QSII: 0.8 ) |
QSII'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.8 Max: 2.4 Current: 0.8 |
| Price/Graham Number | 2 |
QSII's Price/Graham Number is ranked higher than
86% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 2.20 vs. QSII: 2 ) |
QSII'
s 10-Year Price/Graham Number Range
Min: 1.4 Max: 5.4 Current: 2 |
| Earnings Yield (Greenblatt) | 9.10 |
QSII's Earnings Yield (Greenblatt) is ranked higher than
88% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 4.80 vs. QSII: 9.10 ) |
QSII'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.3 Max: 15.5 Current: 9.1 |
| Forward Rate of Return (Yacktman) | 17.83 |
QSII's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 835 Companies in the Global Health Information Services industry. ( Industry Median: 6.38 vs. QSII: 17.83 ) |
QSII'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 17.6 Max: 45.4 Current: 17.83 |
| Industry: | Health Information Services | |
|---|---|---|
| Compare: | CERN, CTRX, ATHN, MDRX, AH | |
| Traded in other countries: | QY1.Germany |
| NextGen Unit of QSII Wins Deal - Analyst Blog May 15 2013 - ZACKS |